RU97120726A - HIGH DOSES OF CHROME TRIPIKOLINATE FOR TREATMENT OF SECOND TYPE DIABETES - Google Patents
HIGH DOSES OF CHROME TRIPIKOLINATE FOR TREATMENT OF SECOND TYPE DIABETESInfo
- Publication number
- RU97120726A RU97120726A RU97120726/14A RU97120726A RU97120726A RU 97120726 A RU97120726 A RU 97120726A RU 97120726/14 A RU97120726/14 A RU 97120726/14A RU 97120726 A RU97120726 A RU 97120726A RU 97120726 A RU97120726 A RU 97120726A
- Authority
- RU
- Russia
- Prior art keywords
- chromium
- tripicolinate
- chromic
- synthetic
- treatment
- Prior art date
Links
- 206010012601 Diabetes mellitus Diseases 0.000 title 1
- CBDQOLKNTOMMTL-UHFFFAOYSA-K Chromium(III) picolinate Chemical compound [N]12=CC=CC=C2C(=O)O[Cr]112([N]3=CC=CC=C3C(=O)O1)[N]1=CC=CC=C1C(=O)O2 CBDQOLKNTOMMTL-UHFFFAOYSA-K 0.000 claims 9
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 5
- 229910052804 chromium Inorganic materials 0.000 claims 5
- 239000011651 chromium Substances 0.000 claims 5
- 210000004369 Blood Anatomy 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 239000008103 glucose Substances 0.000 claims 3
- 201000001421 hyperglycemia Diseases 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 230000000087 stabilizing Effects 0.000 claims 1
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/440,362 | 1995-05-12 | ||
US08/440,362 US6329361B1 (en) | 1995-05-12 | 1995-05-12 | High-dose chromic picolinate treatment of type II diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
RU97120726A true RU97120726A (en) | 1999-09-27 |
RU2195934C2 RU2195934C2 (en) | 2003-01-10 |
Family
ID=23748461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU97120726/14A RU2195934C2 (en) | 1995-05-12 | 1996-05-08 | High doses of chrome tripicolinate for treatment of non-insulin dependent diabetes mellitus (type ii) |
Country Status (15)
Country | Link |
---|---|
US (1) | US6329361B1 (en) |
EP (1) | EP0825861B1 (en) |
JP (1) | JP3699124B2 (en) |
AR (1) | AR004486A1 (en) |
AT (1) | ATE227127T1 (en) |
AU (1) | AU5733796A (en) |
BR (1) | BR9608835A (en) |
DE (1) | DE69624699T2 (en) |
DK (1) | DK0825861T3 (en) |
ES (1) | ES2183952T3 (en) |
IL (1) | IL118222A (en) |
PT (1) | PT825861E (en) |
RU (1) | RU2195934C2 (en) |
WO (1) | WO1996035421A1 (en) |
ZA (1) | ZA963735B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962030A (en) | 1997-03-07 | 1999-10-05 | Akesis Pharmaceuticals, Inc. | Dietary supplement and method of treatment for diabetic control |
US5789401A (en) * | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
AU751431B2 (en) * | 1997-08-08 | 2002-08-15 | Nutrition 21 | Chromium/biotin treatment of type II diabetes |
EP0925790A1 (en) * | 1997-12-17 | 1999-06-30 | Kartar Dr. Lalvani | Vitamin and mineral combinations for the treatment of syndrome X and non-insulin dependent diabetes (NIDDM) |
US5932258A (en) * | 1998-04-06 | 1999-08-03 | The Iams Company | Composition and process for improving glucose metabolism in companion animals |
US5948772A (en) | 1998-08-28 | 1999-09-07 | Ambi Inc. | Chromium picolinate compositions and uses thereof |
US6143301A (en) * | 1998-08-28 | 2000-11-07 | Ambi Inc. | Chromium picolinate compositions and uses thereof |
US5905075A (en) * | 1998-08-28 | 1999-05-18 | Ambi Inc. | Chromium nicotinate compositions and uses thereof |
US6852760B1 (en) | 1998-09-17 | 2005-02-08 | Akesis Pharmaceuticals, Inc. | Compositions and methods for treatment for glucose metabolism disorders |
US6376549B1 (en) | 1998-09-17 | 2002-04-23 | Akesis Pharmaceuticals, Inc. | Metforimin-containing compositions for the treatment of diabetes |
CN1665566A (en) | 2000-09-21 | 2005-09-07 | 营养21公司 | Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c |
AU2003226313A1 (en) * | 2002-04-23 | 2003-11-10 | Nutrition 21, Inc. | Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
CN100457122C (en) * | 2002-05-14 | 2009-02-04 | 尼普洛株式会社 | Medicine for prevention of and treatment for amyloidosis |
US6831077B2 (en) * | 2002-07-25 | 2004-12-14 | Comprehensive Neuroscience, Inc. | Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation |
US20050019435A1 (en) * | 2003-07-21 | 2005-01-27 | Jeffrey Young | Method of treating non-insulin dependent diabetes mellitus and related complications |
US20050085454A1 (en) * | 2003-10-16 | 2005-04-21 | Natreon Inc. | Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance |
EP2120930A4 (en) * | 2007-01-31 | 2012-12-05 | Nutrition 21 Inc | Use of chromium histidinate for treatment of cardiometabolic disorders |
EP3050568B1 (en) | 2007-03-13 | 2020-12-02 | JDS Therapeutics, LLC | Methods and compositions for the sustained release of chromium |
WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
EP3513790A1 (en) | 2009-07-01 | 2019-07-24 | JDS Therapeutics, LLC | Chromium complexes as enhancers of brain glucose transporters |
ES2927800T3 (en) | 2011-03-01 | 2022-11-11 | Nutrition 21 Llc | Insulin and chromium composition for the treatment and prevention of diabetes, hypoglycemia and related disorders |
CN107404902A (en) | 2015-02-13 | 2017-11-28 | 马斯公司 | Pet food feeds system |
GB2564295A (en) | 2016-02-11 | 2019-01-09 | Nutrition 21 Llc | Chromium containing compositions for improving health and fitness |
US10820617B1 (en) | 2018-03-29 | 2020-11-03 | Government Of The United States, As Represented By The Secretary Of The Air Force | All inclusive electrolytes, vitamins, and protein powder training supplement |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4315927A (en) * | 1980-08-08 | 1982-02-16 | The United States Of America As Represented By The Secretary Of Agriculture | Dietary supplementation with essential metal picolinates |
US5087623A (en) * | 1988-05-31 | 1992-02-11 | Nitrition 21 | Chromic picolinate treatment |
US5164384A (en) | 1991-06-19 | 1992-11-17 | Metagenics, Inc. | Anabolic mineral formula |
-
1995
- 1995-05-12 US US08/440,362 patent/US6329361B1/en not_active Expired - Lifetime
-
1996
- 1996-05-08 PT PT96915595T patent/PT825861E/en unknown
- 1996-05-08 AT AT96915595T patent/ATE227127T1/en not_active IP Right Cessation
- 1996-05-08 DE DE69624699T patent/DE69624699T2/en not_active Expired - Fee Related
- 1996-05-08 RU RU97120726/14A patent/RU2195934C2/en not_active IP Right Cessation
- 1996-05-08 BR BR9608835-4A patent/BR9608835A/en not_active IP Right Cessation
- 1996-05-08 DK DK96915595T patent/DK0825861T3/en active
- 1996-05-08 WO PCT/US1996/006493 patent/WO1996035421A1/en active IP Right Grant
- 1996-05-08 AU AU57337/96A patent/AU5733796A/en not_active Abandoned
- 1996-05-08 ES ES96915595T patent/ES2183952T3/en not_active Expired - Lifetime
- 1996-05-08 JP JP53421996A patent/JP3699124B2/en not_active Expired - Lifetime
- 1996-05-08 EP EP96915595A patent/EP0825861B1/en not_active Expired - Lifetime
- 1996-05-10 ZA ZA963735A patent/ZA963735B/en unknown
- 1996-05-10 IL IL11822296A patent/IL118222A/en not_active IP Right Cessation
- 1996-05-10 AR ARP960102526A patent/AR004486A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU97120726A (en) | HIGH DOSES OF CHROME TRIPIKOLINATE FOR TREATMENT OF SECOND TYPE DIABETES | |
ABERNETHY et al. | Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients: altered electrocardiographic and hypotensive responses | |
Roseman | Dilantin toxicity: a clinical and electroencephalographic study | |
Aizenberg et al. | Painful ejaculation associated with antidepressants in four patients. | |
EP1570823A3 (en) | Substained analgesia achieved with buprenorphine | |
YU49083B (en) | Process for obtaining pharmaceutical composition containing budesonide and formoterol | |
RU2002114820A (en) | A method for treating diabetes | |
Jackson et al. | Clinical trial of pyridoxine to reduce vincristine neurotoxicity | |
RO116771B1 (en) | Method for preventing or treating the addiction on, tolerance or abuse of benzodiazepines | |
US5654334A (en) | Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
RU95113499A (en) | METHOD FOR INCREASING URINITATION IN HUMAN, METHOD FOR REDUCING LEVELS OF CHOLESTEROL AND LOW DENSITY LIPOPROTEINS, APPLICATION OF (+) DOXAZOSINE | |
JP2947044B2 (en) | Adjuvant therapy for immunodeficiency syndrome treatment | |
Latasch et al. | Respiratory safety | |
EP0764025B1 (en) | Method and medicine for alleviating jet lag | |
Gobeaux et al. | Midazolam and flumazenil in ophthalmology | |
Bolte et al. | Case of fluoxetine-induced remission of Raynaud's phenomenon—a case report | |
ATE247462T1 (en) | USE OF METFORMIN FOR WEIGHT GAIN ASSOCIATED WITH VALPROATE AND OTHER PSYCHOTROPIC DRUGS | |
RU95112520A (en) | APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS | |
Bibile et al. | Pantothenol and the burning feet syndrome | |
Weksler et al. | Lidocaine pretreatment effectively decreases the incidence of hiccups during methohexitone administration for dilatation and curettage | |
Thomas et al. | A multidimensional comparison of nurse and patient controlled analgesia in the management of acute postsurgical pain. | |
Rappolt et al. | Use of Inderal (propranolol-Ayerst) in Ia (early stimulative) and Ib (advanced stimulative) classification of cocaine and other sympathomimetic reactions | |
Ananth et al. | Intramuscular lorazepam: A double-blind comparison with diazepam and placebo | |
ROTH et al. | The effects of midazolam and temazepam on sleep and performance when administered in the middle of the night |